nVenture’s performance in Q4 2024 was marked by the initiation of commercial sales from its Excelsius product line. While the revenue figures were promising, the company faced significant losses due ...

nVenture's performance in Q4 2024 was marked by the initiation of commercial sales from its Excelsius product line. While the revenue figures were promising, the company faced significant losses due ...

nVenture's performance in Q4 2024 was marked by the initiation of commercial sales from its Excelsius product line. While the revenue figures were promising, the company faced significant losses ...

As a result of the merger, Nevro is now a wholly owned subsidiary of Globus. According to InvestingPro data, Nevro maintained a healthy gross profit margin of 65.98% prior to the merger ...

AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed ...

Globus Medical (GMED) announced the completion of its previously disclosed acquisition of Nevro (NVRO). The acquisition of Nevro further expands Globus Medical’s presence in the musculoskeletal ...

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro. In February, Audobon, Pennsylvania-based Globus agreed to acquire all shares of ...

Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release. The acquisition expands Globus Medical’s reach in the musculoskeletal market ...